Exogenous BMP7 corrects plasma iron overload and bone loss in Bmp6-/- mice
Authors:
- Martina PaukMPMartina Pauk
- Lovorka GrgurevicLGLovorka Grgurevic
- Jelena BrkljacicJBJelena Brkljacic
- Vera KufnerVKVera Kufner
- Tatjana Bordukalo-NiksicTBTatjana Bordukalo-Niksic
- Kristina GrabusicKGKristina Grabusic
- Genadij RazdorovGRGenadij Razdorov
- Dunja RogicDRDunja Rogic
- Marijan ZuvicMZMarijan Zuvic
- Hermann OppermannHOHermann Oppermann
- Jodie L. BabittJBJodie L. Babitt
- Herbert Y. LinHLHerbert Y. Lin
- 11 October 2014
- journal article
- Published by Springer Nature in International Orthopaedics
- Vol. 39 (1) , 161-172
Abstract
Iron overload accelerates bone loss in mice lacking the bone morphogenetic protein 6 (Bmp6) gene, which is the key endogenous regulator of hepcidin, iron homeostasis gene. We investigated involvement of other BMPs in preventing haemochromatosis and subsequent osteopenia in Bmp6-/- mice. Iron-treated wild-type (WT) and Bmp6-/- mice were analysed for hepcidin messenger RNA (mRNA) and tissue and blood BMP levels by quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR), immunohistochemistry, Western blot, enzyme-linked immunosorbent assay (ELISA) and proximity extension assay. BMPs labeled with technetium-99m were used in pharmacokinetic studies. In WT mice, 4 h following iron challenge, liver Bmp6 and hepcidin expression were increased, while expression of other Bmps was not affected. In parallel, we provided the first evidence that BMP6 circulates in WT mice and that iron increased the BMP6 serum level and the specific liver uptake of 99mTc-BMP6. In Bmp6-/- mice, iron challenge led to blunted activation of liver Smad signaling and hepcidin expression with a delay of 24 h, associated with increased Bmp5 and Bmp7 expression and increased Bmp2, 4, 5 and 9 expression in the duodenum. Liver Bmp7 expression and increased circulating BMP9 eventually contributed to the late hepcidin response. This was further supported by exogenous BMP7 therapy resulting in an effective hepcidin expression followed by a rapid normalisation of plasma iron values and restored osteopenia in Bmp6-/- mice. In Bmp6-/- mice, iron activated endogenous compensatory mechanisms of other BMPs that were not sufficient for preventing hemochromatosis and bone loss. Administration of exogenous BMP7 was effective in correcting the plasma iron level and bone loss, indicating that BMP6 is an essential but not exclusive in vivo regulator of iron homeostasis.Keywords
This publication has 38 references indexed in Scilit:
- Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in miceHepatology, 2011
- Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in miceHepatology, 2011
- BMP6 Treatment Compensates for the Molecular Defect and Ameliorates Hemochromatosis in Hfe Knockout MiceGastroenterology, 2010
- The Role of Hepatocyte Hemojuvelin in the Regulation of Bone Morphogenic Protein-6 and Hepcidin Expression in VivoJournal of Biological Chemistry, 2010
- BMP6 is a key endogenous regulator of hepcidin expression and iron metabolismNature Genetics, 2009
- Bone Morphogenetic Protein-9 Is a Circulating Vascular Quiescence FactorCirculation Research, 2008
- Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolismNature Chemical Biology, 2007
- Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balanceJournal of Clinical Investigation, 2007
- Detection of bone and cartilage-related proteins in plasma of patients with a bone fracture using liquid chromatography–mass spectrometryInternational Orthopaedics, 2007
- Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6Proceedings of the National Academy of Sciences, 2006